Tibulizumab

A4DAB263 | Phase-I
TNFSF13B/CD257/BAFF;IL17A
G4;G4 / None
Eli Lilly
Phase-I
Bispecific Mixed mAb and scFv
LY-3090106 LY3090106 LY 3090106 ZB-106 ZB106 ZB 106
—
IMGT PubChem (374363834) PubChem (381128114) PubChem (384403631) PubChem (404772296) PubChem (472415124) PubChem (476262884) PubChem (476269451) Thera-SAbDab YAbS
Avg A4D Score
-0.6849
Score Range
-0.68
Structures
1
Avg. A4D Score per Structure
pH at Min / Max Aggregation Propensity

Associated Structural Profiles Level 2

Structure ID Source PDB Seq. Identity Avg. A4D Score pH (Min Agg.) pH (Max Agg.) Score CDR Score non-CDR
A4DAB263_6nov_A_B 6nov 97% -0.6849 6.5 4.0 -0.1857 -0.752